For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| ADX-2191 | ADX-2191 (intravitreal methotrexate 0.8%) injected thirteen times over sixteen weeks | 0 | None | 0 | 68 | 39 | 68 | View |
| Standard Surgical Care | Standard surgical care performed | 0 | None | 1 | 38 | 24 | 38 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Dizziness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Punctate keratitis | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Eye pain | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Keratitis | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Cystoid macular oedema | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Eye irritation | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Cataract | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Cataract subcapsular | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Conjunctival haemorrhage | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Corneal oedema | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Dry eye | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Macular fibrosis | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Vision blurred | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Anterior chamber inflammation | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Macular Oedema | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Corneal epithelium defect | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Anterior chamber cell | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Hypotony of eye | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Iris adhesions | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Retinal haemorrhage | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Anterior chamber fibrin | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Eye pruritus | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Posterior capsule opacification | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Foreign body in eye | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Hyphaema | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Post procedural inflammation | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Intraocular pressure increased | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Blood pressure increased | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |